NCT04702932View on ClinicalTrials.gov

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2036

Conditions

Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaWaldenstrom Macroglobulinemia

Trial Locations (1)

75020

Service de Médecine Interne, Paris

All Listed Sponsors

collaborator

INSERM UMR 1163

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04702932 - Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies | Biotech Hunter | Biotech Hunter